{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":6,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":6,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c86d86eb121f","filters":{"venue":"Journal of Experimental Therapeutics and Oncology"}},"results":[{"id":"W2150577846","doi":"10.1046/j.1359-4117.2003.01067.x","title":"The reversal of multidrug resistance: an update","year":2003,"lang":"en","type":"review","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Citation; Library science; Resistance (ecology); Computer science; Biology","authors":[{"name":"John A. Kellen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06783562721478266,"gpt":0.4131665889847533,"spread":0.3453309617699707,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001617601,0.001674745,0.003388393,0.003087564,0.0004185997,0.00236265,0.00198258,0.002418685,0.003902639],"category_scores_gemma":[0.001874565,0.0005860929,0.0008704487,0.003102272,0.001004871,0.003409381,0.0009212857,0.003667721,0.002734209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009067407,"about_ca_system_score_gemma":0.001568343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001321251,"about_ca_topic_score_gemma":0.003072887,"domain_scores_codex":[0.9996474,0.00005942244,0.00007467892,0.00006077639,0.0001205054,0.00003725575],"domain_scores_gemma":[0.9988269,0.0005756617,0.0001226992,0.00003839687,0.0003170299,0.0001193136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002786957,0.0002028441,0.0002218528,0.01346409,0.0001372676,0.0004471307,0.00005891389,0.000335401,0.001730558,0.001956381,0.06944022,0.9117267],"study_design_scores_gemma":[0.0001277542,0.0002824173,0.0006589391,0.002236756,0.0002627129,0.001868887,0.00005267484,0.000145759,0.0004635315,0.0009553644,0.9929157,0.00002944661],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001255113,0.9974929,0.0002168112,0.0005496561,0.0009840539,0.000007487155,0.00002276985,0.00001390991,0.0005869773],"genre_scores_gemma":[0.0005082853,0.997278,0.0003661477,0.0005999358,0.000701118,0.000008982042,0.00004349112,0.000002633578,0.000491267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003902639,"threshold_uncertainty_score":0.01305562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111254733","doi":"10.1046/j.1359-4117.2003.01075.x","title":"Combined treatment of Bcl‐2 antisense oligodeoxynucleotides (G3139), p‐glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug‐resistant growth of drug‐resistant breast cancer in severely combined immunodeficient mice","year":2003,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celator Pharmaceuticals (Canada); University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Drug; Doxorubicin; Liposome; P-glycoprotein; Chemistry; Drug resistance; Breast cancer; Pharmacology; Cancer research; Cancer; Multiple drug resistance; Chemotherapy; Medicine; Biochemistry; Biology; Internal medicine; Microbiology; Antibiotics","authors":[{"name":"Daniel E. Lopes de Menezes","is_ca":true},{"name":"Yanping Hu","is_ca":false},{"name":"Lawrence D. Mayer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01375766376512696,"gpt":0.2769492816888141,"spread":0.2631916179236871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001242806,0.0004181273,0.0003941671,0.0002606162,0.0001079498,0.0001695053,0.0002171418,0.0002856426,0.0006376283],"category_scores_gemma":[0.00008223804,0.0001672537,0.0002040548,0.0001624491,0.0002063788,0.0001739865,0.0001377938,0.0006239575,0.0002143295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001904269,"about_ca_system_score_gemma":0.0002745884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005653743,"about_ca_topic_score_gemma":0.0013545,"domain_scores_codex":[0.9998623,0.00002207114,0.00001385562,0.00002978353,0.00003404563,0.00003793681],"domain_scores_gemma":[0.9999179,0.00001189791,0.00002240192,0.00001078411,0.000006232635,0.00003087785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002407751,0.0001052458,0.0001020461,0.00001760306,0.000005754336,0.00002879804,0.000008713143,0.00007774225,0.9982018,0.00003970269,0.00003149271,0.001140369],"study_design_scores_gemma":[0.0001102581,0.002090583,0.001558618,0.000002837073,0.0000257685,0.0001438941,0.000007132597,0.0008190348,0.9944155,0.00002165065,0.0008002393,0.000004503718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980173,0.0005303089,0.0006217441,0.00005896016,0.00002712013,0.00003412333,0.0001218302,0.00007408644,0.0005145376],"genre_scores_gemma":[0.9969864,0.0005245305,0.001207452,0.00004515885,0.0000141732,0.00004722152,0.0002277102,0.00001059922,0.0009367266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006376283,"threshold_uncertainty_score":0.002133071,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071404901","doi":"10.1046/j.1359-4117.2003.01063.x","title":"Superinduction of P‐glycoprotein messenger RNA in vivo in the presence of transcriptional inhibitors","year":2003,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of Northern British Columbia","funders":"National Cancer Institute","keywords":"In vivo; Chemistry; Messenger RNA; Five-prime cap; RNA; P-glycoprotein; Glycoprotein; Biochemistry; Cell biology; Molecular biology; Biology; Gene; Genetics; Antibiotics; RNA editing; Multiple drug resistance","authors":[{"name":"Chow H. Lee","is_ca":true},{"name":"Victor Ling","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03270574526117896,"gpt":0.3164024355822708,"spread":0.2836966903210918,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005588527,0.0006022737,0.0004281682,0.0004372817,0.0001341012,0.0004096333,0.0003618846,0.0003585272,0.001781094],"category_scores_gemma":[0.0004236234,0.0003125377,0.0004844703,0.0003329517,0.0004776211,0.0002322582,0.0002687933,0.00140882,0.0005786965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004122059,"about_ca_system_score_gemma":0.0003726105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004646334,"about_ca_topic_score_gemma":0.001006398,"domain_scores_codex":[0.9994882,0.0001306761,0.00004424226,0.0001242741,0.0001144263,0.00009817942],"domain_scores_gemma":[0.9989335,0.0005520115,0.0001707195,0.0001365857,0.00007648415,0.0001306857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001453026,0.00004344812,0.00002969739,0.00001726718,0.00000324969,0.00001114343,0.00001288257,0.00004281844,0.9991865,0.00004826936,0.0000224318,0.000436987],"study_design_scores_gemma":[0.00002199495,0.0009022572,0.0006549831,0.000004726013,0.0000124149,0.00003005692,0.00001005888,0.0008059843,0.9965115,0.00003658957,0.001004784,0.000004604193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9745443,0.003933813,0.01627482,0.0003053138,0.0002474207,0.0002301618,0.001032756,0.0004462741,0.002985087],"genre_scores_gemma":[0.9629407,0.003312627,0.01916532,0.0002908159,0.0001883782,0.0005234283,0.00387154,0.0002501997,0.00945699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001781094,"threshold_uncertainty_score":0.005958378,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975200147","doi":"10.1111/j.1533-869x.2003.01099.x","title":"Combining doxorubicin and liposomal anti‐HER‐2/NEU antisense oligodeoxynucleotides to treat HER‐2/NEU‐expressing MDA‐MB‐435 breast tumor model","year":2003,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celator Pharmaceuticals (Canada); University of British Columbia","funders":"","keywords":"HER2/neu; Liposome; Doxorubicin; Cancer research; Pharmacology; Breast tumor; Medicine; Biology; Breast cancer; Internal medicine; Chemotherapy; Cancer; Biochemistry","authors":[{"name":"Dawn Waterhouse","is_ca":true},{"name":"Karen A. Gelmon","is_ca":false},{"name":"Dana Masin","is_ca":false},{"name":"Marcel B. Bally","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04966820151808032,"gpt":0.3680381729148243,"spread":0.3183699713967439,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001640977,0.0003839364,0.0004425936,0.0001813569,0.00007278163,0.0001874146,0.0001645943,0.0002639196,0.0004349868],"category_scores_gemma":[0.0000662379,0.0001353886,0.0001861599,0.0001091921,0.0001141433,0.0002102156,0.0001231134,0.0003776559,0.0001391127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002037772,"about_ca_system_score_gemma":0.0002486835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008100905,"about_ca_topic_score_gemma":0.001931723,"domain_scores_codex":[0.9999182,0.00001209915,0.000006463998,0.00002212804,0.00001982493,0.00002128256],"domain_scores_gemma":[0.9999641,0.000006019378,0.000008708512,0.000003314131,0.000005707572,0.00001216027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001356067,0.00008558768,0.00007425314,0.00004434834,0.000008126878,0.00002113627,0.000009734451,0.0001334421,0.9974584,0.00004542373,0.00002853596,0.001955589],"study_design_scores_gemma":[0.00009089307,0.004909542,0.001402529,0.000008543897,0.00007125508,0.0001616719,0.00001566697,0.00177344,0.9882767,0.0000299489,0.003249027,0.00001075433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909763,0.00255849,0.005075322,0.0001022938,0.00009975528,0.0001276683,0.0001312712,0.00006837907,0.0008606117],"genre_scores_gemma":[0.9892467,0.002560907,0.005325818,0.00005733308,0.00002947285,0.00011948,0.0002188296,0.00001577952,0.002425739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008100905,"threshold_uncertainty_score":0.001610756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2153203656","doi":"10.1046/j.1359-4117.2002.01061.x","title":"Gene therapy in cancer","year":2002,"lang":"en","type":"review","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Gene; Genetics; Cancer; Genetic enhancement; Biology; Bioinformatics; Biotechnology","authors":[{"name":"John A. Kellen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1388047891721835,"gpt":0.4611277528883571,"spread":0.3223229637161736,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008842587,0.0009773117,0.001239543,0.001998221,0.0006697062,0.001340804,0.0008836165,0.002368198,0.005768617],"category_scores_gemma":[0.0006701819,0.0002291254,0.0004182226,0.002429212,0.001488545,0.001933366,0.0009526795,0.003060916,0.004761674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001322229,"about_ca_system_score_gemma":0.001066377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00126412,"about_ca_topic_score_gemma":0.002413243,"domain_scores_codex":[0.9996549,0.00009217685,0.00002295032,0.00005351817,0.0001463837,0.00003002209],"domain_scores_gemma":[0.9997185,0.0001304204,0.00002357469,0.00002086659,0.0000747337,0.0000319389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006772294,0.0001103011,0.00017126,0.004854886,0.00003807886,0.0004454918,0.0001671024,0.0005426468,0.003267105,0.02250386,0.07868227,0.8891493],"study_design_scores_gemma":[0.00001658116,0.00005396899,0.0002093112,0.0008273746,0.00001253361,0.001230649,0.00003983696,0.00005681229,0.0004802416,0.004629216,0.9924346,0.000008972292],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001199033,0.9938346,0.0003115358,0.0007380836,0.0007891376,0.00001011958,0.000006900966,0.00001191096,0.004177875],"genre_scores_gemma":[0.001305221,0.9920664,0.0004847131,0.0009132921,0.0004825536,0.00001860964,0.00001936282,0.000004100897,0.004705744],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005768617,"threshold_uncertainty_score":0.01929796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122355107","doi":"10.1046/j.1359-4117.2002.1009x.x","title":"Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P‐glycoprotein","year":2002,"lang":"en","type":"article","venue":"Journal of Experimental Therapeutics and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"P-glycoprotein; Intracellular; Multiple drug resistance; Cytotoxicity; Verapamil; Chemistry; Pharmacology; In vitro; Biochemistry; Biology","authors":[{"name":"Lawrence D. Mayer","is_ca":true},{"name":"Kye‐Taek Lim","is_ca":false},{"name":"D Hartley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03803544286131853,"gpt":0.3178484084531365,"spread":0.279812965591818,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001414934,0.0006007038,0.0005627193,0.0002549415,0.0001906549,0.0005346119,0.0002694463,0.0005428394,0.001519118],"category_scores_gemma":[0.0002113418,0.0002821293,0.0003435735,0.0001545601,0.0003040899,0.0007256123,0.0002899336,0.0005827947,0.0006013483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003282086,"about_ca_system_score_gemma":0.0001245024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000247422,"about_ca_topic_score_gemma":0.0002219321,"domain_scores_codex":[0.999858,0.00002666332,0.00001407973,0.00003131309,0.00003257015,0.00003731869],"domain_scores_gemma":[0.9998198,0.00004860845,0.00005827248,0.00001911874,0.00002486845,0.00002932478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001106729,0.00002049979,0.0002106713,0.00003012549,0.00000168958,0.0001636553,0.00002544383,0.00003431932,0.9983576,0.0001274945,0.00001122837,0.0009066378],"study_design_scores_gemma":[0.00004643138,0.0004669765,0.01171981,0.000007063966,0.00001666568,0.001180007,0.00007082817,0.001513776,0.9837112,0.0002199275,0.001035884,0.00001153318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891697,0.002261758,0.006452514,0.0001260635,0.00001650881,0.00005564105,0.0001904192,0.00008876519,0.001638705],"genre_scores_gemma":[0.9929035,0.0008831609,0.004366551,0.00003766674,0.00001301567,0.0000593143,0.0002280255,0.000022257,0.001486384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001519118,"threshold_uncertainty_score":0.005081952,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}